talactoferrin alfa has been researched along with Diabetic Foot in 1 studies
talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006
Diabetic Foot: Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lyons, TE | 1 |
| Miller, MS | 1 |
| Serena, T | 1 |
| Sheehan, P | 1 |
| Lavery, L | 1 |
| Kirsner, RS | 1 |
| Armstrong, DG | 1 |
| Reese, A | 1 |
| Yankee, EW | 1 |
| Veves, A | 1 |
1 trial available for talactoferrin alfa and Diabetic Foot
| Article | Year |
|---|---|
Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.
Topics: Administration, Topical; Diabetic Foot; Dose-Response Relationship, Drug; Female; Humans; Lactoferri | 2007 |